In last trading session, Larimar Therapeutics Inc (NASDAQ:LRMR) saw 2.03 million shares changing hands with its beta currently measuring 0.83. Company’s recent per share price level of $3.25 trading at $0.26 or 8.70% at ring of the bell on the day assigns it a market valuation of $208.09M. That closing price of LRMR’s stock is at a discount of -244.62% from its 52-week high price of $11.20 and is indicating a premium of 50.46% from its 52-week low price of $1.61.
For Larimar Therapeutics Inc (LRMR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.08. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Larimar Therapeutics Inc (NASDAQ:LRMR) trade information
Upright in the green during last session for gaining 8.70%, in the last five days LRMR remained trading in the green while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $3.25 price level, adding 2.4% to its value on the day. Larimar Therapeutics Inc’s shares saw a change of -60.02% in year-to-date performance and have moved 20.82% in past 5-day. Larimar Therapeutics Inc (NASDAQ:LRMR) showed a performance of 73.80% in past 30-days.
Wall Street analysts have assigned a consensus price target of 18.5 to the stock, which implies a rise of 82.43% to its current value. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 25. It follows that stock’s current price would drop -330.77% in reaching the projected high whereas dropping to the targeted low would mean a loss of -330.77% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 50.78% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -45.43% while estimates for its earnings growth in next 5 years are of -7.57%.
Larimar Therapeutics Inc (NASDAQ:LRMR)’s Major holders
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is the top institutional holder at LRMR for having 21.23 million shares of worth $153.93 million. And as of 2024-06-30, it was holding 33.278 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 6.05 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.4752 of outstanding shares, having a total worth of $43.83 million.
